Valuation: 3SBio Inc.

Capitalization 5.21TCr 5.9TCr 754.92Cr 638.28Cr 582.9Cr 558.04Cr 1.03TCr 68TCr 1.07TCr 6.8TCr 2.69TCr 33TCr 2.83TCr 2.77TCr 1,16000Cr P/E ratio 2025 *
5.33x
P/E ratio 2026 * 15.7x
Enterprise value 4.23TCr 4.79TCr 613.13Cr 518.4Cr 473.42Cr 453.23Cr 837.31Cr 56TCr 868.01Cr 5.52TCr 2.19TCr 27TCr 2.3TCr 2.25TCr 94TCr EV / Sales 2025 *
2.3x
EV / Sales 2026 * 3.41x
Free-Float
72.15%
Yield 2025 *
3.8%
Yield 2026 * 2.37%
1 day+0.94%
1 week-3.59%
Current month+1.37%
1 month-10.80%
3 months-28.64%
6 months-29.58%
Current year-2.32%
1 week 23
Extreme 23
24.3
1 month 22.3
Extreme 22.3
26.48
Current year 22.3
Extreme 22.3
29.3
1 year 6.44
Extreme 6.44
36.8
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2006
Director of Finance/CFO - 03/07/2023
Corporate Officer/Principal 56 27/11/2014
Director TitleAgeSince
Chairman 63 03/04/2012
Director/Board Member 56 11/06/2012
Director/Board Member 57 01/06/2015
Change 5d. change 1-year change 3-years change Capi.($)
+0.94%-3.59%+264.51%+181.86% 754.86Cr
-1.20%+5.12%+17.80%+5.98% 8.14TCr
+0.39%+7.80%+54.55%+262.09% 6.37TCr
-0.52%+71.00%+71.00%+71.00% 5.48TCr
+0.78%-6.55%-42.10%-48.81% 5.16TCr
-0.46%+3.51%+42.45%-29.73% 2.87TCr
+0.06%+1.11%+43.65%+28.05% 2.01TCr
+0.56%-0.61%+131.43%+124.43% 1.98TCr
+4.03%+4.61%+33.16%-73.63% 1.72TCr
+3.07%+3.72%+32.81%+78.57% 1.58TCr
Average +0.77%+1.04%+64.93%+59.98% 3.61TCr
Weighted average by Cap. +0.17%+1.37%+40.00%+61.22%

Financials

2025 *2026 *
Net sales 1.84TCr 2.09TCr 267.02Cr 225.77Cr 206.18Cr 197.38Cr 364.65Cr 24TCr 378.02Cr 2.41TCr 952.47Cr 12TCr 1TCr 980.8Cr 41TCr 1.15TCr 1.3TCr 166.31Cr 140.62Cr 128.42Cr 122.94Cr 227.12Cr 15TCr 235.45Cr 1.5TCr 593.24Cr 7.27TCr 623.76Cr 610.89Cr 26TCr
Net income 958.72Cr 1.08TCr 138.8Cr 117.36Cr 107.17Cr 102.6Cr 189.55Cr 13TCr 196.5Cr 1.25TCr 495.11Cr 6.07TCr 520.58Cr 509.83Cr 21TCr 326.12Cr 369Cr 47Cr 40Cr 36Cr 35Cr 64Cr 4.28TCr 67Cr 425.28Cr 168.41Cr 2.06TCr 177.08Cr 173.42Cr 7.25TCr
Net Debt -979.32Cr -1.11TCr -141.79Cr -119.88Cr -109.48Cr -104.81Cr -193.63Cr -13TCr -200.73Cr -1.28TCr -505.75Cr -6.2TCr -531.77Cr -520.79Cr -22TCr -1.3TCr -1.47TCr -187.93Cr -158.9Cr -145.11Cr -138.92Cr -256.65Cr -17TCr -266.06Cr -1.69TCr -670.35Cr -8.22TCr -704.84Cr -690.29Cr -29TCr
Logo 3SBio Inc.
3SBio Inc is an investment holding company mainly engaged in the development, production, marketing and sale of pharmaceutical products. The Company’s core products include several biopharmaceutical drugs, TPIAO, recombinant human erythropoietin(rhEPO) products, with brand of EPIAO and SEPO, Yisaipu, Cipterbin and a small molecule drug, Mandi and tumor necrosis factor (TNF). Through its subsidiaries, the Company is engaged in project management and consultation. The Company still engages in developing innovative biological products, including mAbs, bi-specific antibodies and fusion proteins, and a number of small molecule drugs, both innovative and generic, in the areas of nephrology, oncology, auto-immune and inflammatory diseases, ophthalmology and dermatological diseases. The Company distributes its products within the domestic market and to overseas markets.
Employees
6,268
Date Price Change Volume
16/26/16 23.62 $ +0.94% 11,82,000
13/26/13 23.40 $ -0.17% 78,57,288
12/26/12 23.44 $ -2.82% 1,38,48,070
11/26/11 24.12 $ -1.55% 1,11,01,170
10/26/10 24.50 $ +4.26% 2,40,13,480
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
20.88CNY
Average target price
34.72CNY
Spread / Average Target
+66.29%

Quarterly revenue - Rate of surprise